AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...

Less than a month after reports of takeover talks between AbbVie and Gilgamesh Pharma first emerged, the pair have gone public with details of a $1.2 billion deal – but it is not an acquisition. It ...

Publisher Bandai Namco and developer TYPE-MOON studio BB have delayed Fate/EXTRA full remake Fate/EXTRA Record from its previously announced 2025 release window to spring 2026 for further quality ...

The fate of a cell describes its future identity, or the identity of its daughter cells, before it is actually phenotypically detectable through differentiation or division. Cell fate can be ...

Even though it can be difficult to tell the stories of ten central characters, Eternals did it well enough by showcasing the stories of all of the ten Eternals in one film. One such story that we ...

AT ONE OF the earliest points of our recorded history, the remarkable culture of Mesopotamia flourished, and one of its many versatile and precocious achievements was Gilgamesh, our first recognisable ...

List your movie, TV & celebrity picks.